A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)-Reference-Cited by-同舟云学术

A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)

Published:2018-07-20 Issue:4 Volume:82 Page:585-592
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Tanaka Yusuke,Ueda Yutaka,Nakagawa Satoshi,Matsuzaki Shinya,Kobayashi Eiji,Shiki Yasuhiko,Nishio Yukihiro,Takemura Masahiko,Yamamoto Toshiya,Sawada Kenjiro,Tomimatsu Takuji,Yoshino Kiyoshi,Kimura Tadashi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-018-3648-y/fulltext.html

Reference19 articles.

1. DiSaia PJ, Creasman WT (2017) Clinical gynecologic oncology, 9th edn. Mosby, St. Louis, pp 1–728

2. Aapro MS, van Wijk FH, Bolis G, Chevallier B, van der Burg ME, Poveda A et al.; European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group (2003) Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Ann Oncol 14:441–448

3. Sovak MA, Hensley ML, Dupont J, Ishill N, Alektiar KM, Abu-Rustum N et al (2006) Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study. Gynecol Oncol 103:451–457

4. Brown J, Smith JA, Ramondetta LM, Sood AK, Ramirez PT, Coleman RL et al (2010) Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial. Cancer 116:4973–4979

5. Matulonis U, Campos S, Duska L, Fuller A, Berkowitz R, Gore S et al (2003) A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies. Gynecol Oncol 91:293–298

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer;Journal of Clinical Oncology;2024-07-31

2. E2F7/RAD51AP1 Axis Inhibits Endometrial Cancer Sensitivity to 5-FUviathe Fatty Acid Metabolic Pathway;Anticancer Research;2023-11

3. Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer;The Oncologist;2023-04-07

4. Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer;BMC Cancer;2022-06-21

5. Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052);Journal of Gynecologic Oncology;2022